As of Nov 27
| +1.34 / +1.16%|
The 13 analysts offering 12-month price forecasts for Incyte Corp have a median target of 135.00, with a high estimate of 145.00 and a low estimate of 115.00. The median estimate represents a +15.63% increase from the last price of 116.75.
The current consensus among 14 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.